26/06/2025
DoxyPEP — now in Polish! 🇵🇵🇱 DoxyPEP💊 — the use of doxycycline as post-exposure prophylaxis to prevent bacterial STIs such as syphilis and chlamydia — is receiving growing attention across public health communities. Clinical studies show it can reduce the incidence of these infections by up to 70–90%, particularly among men who have s*x with men and people using HIV PrEP. Its effectiveness in preventing gonorrhoea remains variable due to antibiotic resistance patterns.
Despite promising evidence, DoxyPEP remains a subject of global debate. Concerns around antimicrobial resistance, appropriate patient selection, and ethical considerations on antibiotic use continue to shape the discussion.
📌 In Poland, this conversation is only just beginning.
📌 There are no national clinical guidelines.
📌 It is not reimbursed.
📌 Access depends entirely on a physician’s decision, leaving patients without consistent, equitable options.
📘 To help change that, we’ve adopted and published the Polish version of DoxyPEP Info Note. I hope this publication will help build awareness, inform patient and provider choices, and spark constructive dialogue that could support advocacy for national-level guidance on DoxyPEP as a viable STI prevention strategy.
🙏 I’m grateful to Grzesiek Jezierski for your thoughtful content adaptation; Dorota Nowicka, MD, PhD, for your insightful medical review; Gus Cairns and Robert Hejzak for authoring the original; and to the European AIDS Treatment Group, whose initiative and support made this work possible.
Download the Polish version here:https://www.eatg.org/wp-content/uploads/2025/03/eatg-doxypep-info-note-polish.pdf
